Dive Into Other Topics

Aug 27, 2025

The global healthcare landscape is witnessing a seismic shift, propelled by the rapid integration of smart healthcare technology into everyday medical practice. At the forefront of this transformation are smart medical devices are intelligent tools that combine advanced sensors, wireless connectivity, data analytic...

Aug 22, 2025

Vertex & CRISPR Therapeutics become first companies to submit marketing application for CRISPR gene-editing therapy exa-cel for SCD & TDT.

Jul 10, 2025

Polycythemia vera treatment market is expected to substantially change and it will be dominated by approved products, JAKAFI and BESREMi.

Jul 01, 2025

Although there has been tremendous investment in chronic spontaneous urticaria treatment, there are still gray areas that require attention.

Jun 10, 2025

On 19 May 2023, FDA approved Abbvie-Genmab’s EPKINLY, as the first CD20XCD3 bispecific antibody R/R DLBCL treatment in adults.

Jun 06, 2025

Cloud computing in the healthcare industry is growing at an immense pace. Despite some difficulties, the advantages of cloud computing are more compared to disadvantages

Jun 06, 2025

As per the latest assessment by DelveInsight, the global sleep tech devices market was valued at ~USD 17 billion in 2023, growing at a CAGR of 17.31% during the forecast period from 2024 to 2030 to reach ~USD 44 billion by 2030.

Mar 14, 2025

80+ pharma companies are working to assess challenges & seek opportunities that could influence obesity treatment scenario in coming years.

Mar 02, 2025

On September 29, 2023, FDA approved EXXUA, the ER gepirone hydrochloride tablets by Fabre-Kramer, for major depressive disorder treatment.

Feb 12, 2025

Donanemab is a promising new Alzheimer’s disease treatment. Donanemab has the potential to rule the Alzheimer’s disease market.